JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.82B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.91B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.64B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$895M |
Top Sells
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.89B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.86B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$931M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$889M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$862M |
Sector Composition
| 1 | Technology | 16.95% |
| 2 | Financials | 11.22% |
| 3 | Healthcare | 11.1% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Vishay Precision Group
VPG
$429M
| $5.17M | ﹤0.01% |
210,475
+156,205
| +288% | +$3.84M |
|
2027
Boston Beer
SAM
$2.42B
| $5.17M | ﹤0.01% |
9,631
-17,740
| -65% | -$9.52M |
|
2028
Newmark Group
NMRK
$3.39B
| $5.16M | ﹤0.01% |
1,060,798
-106,751
| -9% | -$519K |
|
2029
Karyopharm Therapeutics
KPTI
$54.3M
| $5.14M | ﹤0.01% |
18,079
+897
| +5% | +$255K |
|
2030
Glaukos
GKOS
$4.72B
| $5.13M | ﹤0.01% |
133,421
+31,735
| +31% | +$1.22M |
|
2031
Standard BioTools
LAB
$527M
| $5.12M | ﹤0.01% |
1,275,958
+254,868
| +25% | +$1.02M |
|
2032
Ovintiv
OVV
$10.9B
| $5.11M | ﹤0.01% |
535,486
-220,172
| -29% | -$2.1M |
|
2033
PennyMac Financial
PFSI
$6.52B
| $5.11M | ﹤0.01% |
122,225
-155,965
| -56% | -$6.52M |
|
2034
Myriad Genetics
MYGN
$698M
| $5.1M | ﹤0.01% |
449,907
+123,305
| +38% | +$1.4M |
|
|
BCPC
2035
Balchem Corporation
BCPC
$4.95B
| $5.1M | ﹤0.01% |
53,741
+3,758
| +8% | +$356K |
|
2036
Community Health Systems
CYH
$413M
| $5.1M | ﹤0.01% |
1,692,936
-1,073,152
| -39% | -$3.23M |
|
|
PETQ
2037
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $5.08M | ﹤0.01% |
145,824
+85,280
| +141% | +$2.97M |
|
|
TWOU
2038
DELISTED
2U, Inc.
TWOU
| $5.08M | ﹤0.01% |
4,458
-5,013
| -53% | -$5.71M |
|
2039
Gogo Inc
GOGO
$1.25B
| $5.07M | ﹤0.01% |
1,604,837
+1,262,914
| +369% | +$3.99M |
|
2040
Rollins
ROL
$27.2B
| $5.07M | ﹤0.01% |
179,246
+5,225
| +3% | +$148K |
|
2041
Invesco Variable Rate Preferred ETF
VRP
$2.21B
| $5.05M | ﹤0.01% |
215,332
-50,927
| -19% | -$1.19M |
|
2042
Insmed
INSM
$30.6B
| $5.04M | ﹤0.01% |
182,977
-12,234
| -6% | -$337K |
|
2043
Yeti Holdings
YETI
$2.89B
| $5.04M | ﹤0.01% |
117,919
-567,160
| -83% | -$24.2M |
|
2044
Conduent
CNDT
$442M
| $5.02M | ﹤0.01% |
2,101,914
+1,758,564
| +512% | +$4.2M |
|
|
DHC
2045
Diversified Healthcare Trust
DHC
$1.05B
| $5.02M | ﹤0.01% |
1,133,885
-1,394,700
| -55% | -$6.17M |
|
2046
Elbit Systems
ESLT
$22.2B
| $5.02M | ﹤0.01% |
36,599
-9,801
| -21% | -$1.34M |
|
2047
NMI Holdings
NMIH
$2.98B
| $5.01M | ﹤0.01% |
311,657
-104,373
| -25% | -$1.68M |
|
|
CIR
2048
DELISTED
CIRCOR International, Inc
CIR
| $5.01M | ﹤0.01% |
196,547
+186,370
| +1,831% | +$4.75M |
|
|
ADAP
2049
Adaptimmune Therapeutics
ADAP
$21.4M
| $5.01M | ﹤0.01% |
500,231
+403,494
| +417% | +$4.04M |
|
2050
WideOpenWest
WOW
$442M
| $4.99M | ﹤0.01% |
947,278
-148,631
| -14% | -$783K |
|